{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:44:20Z","timestamp":1776296660484,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The risk of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in primary Sjogren syndrome (pSS) has rarely been explored. To explore the association between BRONJ and pSS, we conducted a population-based propensity-score-matched cohort study using Taiwan\u2019s National Health Insurance Research Database, including pSS patients receiving antiosteoporotic therapy and patients without pSS receiving antiosteoporotic therapy. A 1:4 matched-pair cohort based on propensity score was created. The stratified Cox proportional hazards model compared the risk of BRONJ in the pSS and non-pSS groups. In the study, 23,280 pSS patients and 28,712,152 controls were enrolled. After matching, 348 patients with pSS receiving antiosteoporotic drugs and 50,145 without pSS receiving antiosteoporotic drugs were included for analysis. The risk of developing BRONJ was 1.96 times higher in pSS patients compared with non-pSS patients after adjustment for age, sex, and comorbidities. No dose\u2013response effect was observed in the bisphosphonate-treated pSS cohorts, documented as the cumulative defined daily doses of either &lt;\u2009224 or \u2265\u2009224 (hazard ratio [HR]: 2.407, 95% confidence interval [CI] 1.412\u20137.790; HR: 2.143, 95% CI 1.046\u20134.393, respectively) increased risk of developing osteonecrosis of the jaw. In conclusion, the risk of BRONJ is significantly higher in patients with pSS compared with the general population.<\/jats:p>","DOI":"10.1038\/s41598-020-80622-5","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:02:30Z","timestamp":1610708550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw"],"prefix":"10.1038","volume":"11","author":[{"given":"Pei-I","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Yun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ching","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hsuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"80622_CR1","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Riachner","year":"2011","unstructured":"Riachner, T. D., Khosla, S. & Hofbauer, L. C. Osteoporosis: now and the future. Lancet 377, 1276\u20131287. https:\/\/doi.org\/10.1016\/S0140-6736(10)62349-5 (2011).","journal-title":"Lancet"},{"key":"80622_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.7150\/ijms.22627","volume":"15","author":"FJ Manzano-Moreno","year":"2018","unstructured":"Manzano-Moreno, F. J. et al. Bisphosphonate modulation of the gene expression of different markers involved in osteoblast physiology: possible implications in bisphosphonate-related osteonecrosis of the jaw. Int. J. Med. Sci. 15, 359\u2013367. https:\/\/doi.org\/10.7150\/ijms.22627 (2018).","journal-title":"Int. J. Med. Sci."},{"key":"80622_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","volume":"17","author":"P Nicoletti","year":"2012","unstructured":"Nicoletti, P. et al. Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3. Oncologist 17, 279\u2013287. https:\/\/doi.org\/10.1634\/theoncologist.2011-0202 (2012).","journal-title":"Oncologist"},{"key":"80622_CR4","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00439-016-1716-0","volume":"135","author":"IW Song","year":"2016","unstructured":"Song, I. W. et al. Identification of susceptibility gene associated with female primary Sjogren\u2019s syndrome in Han Chinese by genome-wide association study. Hum. Genet. 135, 1287\u20131294. https:\/\/doi.org\/10.1007\/s00439-016-1716-0 (2016).","journal-title":"Hum. Genet."},{"key":"80622_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick, C. G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15\u201325. https:\/\/doi.org\/10.1002\/art.23177 (2008).","journal-title":"Arthritis Rheum."},{"key":"80622_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1749-6632.2010.05876.x","volume":"1218","author":"AI Zavras","year":"2011","unstructured":"Zavras, A. I. The impact of bisphosphonates on oral health: Lessons from the past and opportunities for the future. Ann. N. Y. Acad. Sci. 1218, 55\u201361. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05876.x (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"80622_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","volume":"44","author":"IR Reid","year":"2009","unstructured":"Reid, I. R. Osteonecrosis of the jaw: who gets it, and why?. Bone 44, 4\u201310. https:\/\/doi.org\/10.1016\/j.bone.2008.09.012 (2009).","journal-title":"Bone"},{"key":"80622_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4081\/reumatismo.2017.983","volume":"69","author":"A Fassio","year":"2017","unstructured":"Fassio, A. et al. Drug-induced osteonecrosis of the jaw: the state of the art. Reumatismo 69, 9\u201315. https:\/\/doi.org\/10.4081\/reumatismo.2017.983 (2017).","journal-title":"Reumatismo"},{"key":"80622_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12787","author":"E Eleutherakis-Papaiakovou","year":"2017","unstructured":"Eleutherakis-Papaiakovou, E. & Bamias, A. Antiresorptive treatment-associated ONJ. Eur J Cancer Care Engl https:\/\/doi.org\/10.1111\/ecc.12787 (2017).","journal-title":"Eur J Cancer Care Engl"},{"key":"80622_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/odi.12490","volume":"22","author":"O Di Fede","year":"2016","unstructured":"Di Fede, O. et al. BRONJ in patients with rheumatoid arthritis: a multicenter case series. Oral. Dis. 22, 543\u2013548. https:\/\/doi.org\/10.1111\/odi.12490 (2016).","journal-title":"Oral. Dis."},{"key":"80622_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","volume":"16","author":"J Chang","year":"2018","unstructured":"Chang, J., Hakam, A. E. & McCauley, L. K. Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw. Curr. Osteoporos. Rep. 16, 584\u2013595. https:\/\/doi.org\/10.1007\/s11914-018-0474-4 (2018).","journal-title":"Curr. Osteoporos. Rep."},{"key":"80622_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","volume":"24","author":"A Badros","year":"2006","unstructured":"Badros, A. et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J. Clin. Oncol. 24, 945\u2013952. https:\/\/doi.org\/10.1200\/JCO.2005.04.2465 (2006).","journal-title":"J. Clin. Oncol."},{"key":"80622_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","volume":"66","author":"JH Wessel","year":"2008","unstructured":"Wessel, J. H., Dodson, T. B. & Zavras, A. I. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J. Oral. Maxillofac. Surg. 66, 625\u2013631. https:\/\/doi.org\/10.1016\/j.joms.2007.11.032 (2008).","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"80622_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/FPC.0b013e328335729c","volume":"21","author":"L Gong","year":"2011","unstructured":"Gong, L., Altman, R. B. & Klein, T. E. Bisphosphonates pathway. Pharmacogenet Genom. 21, 50\u201353. https:\/\/doi.org\/10.1097\/FPC.0b013e328335729c (2011).","journal-title":"Pharmacogenet Genom."},{"key":"80622_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jmb.2007.06.006","volume":"371","author":"D Fritz","year":"2007","unstructured":"Fritz, D. & Stefanovic, B. RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx 1. J. Mol. Biol. 371, 585\u2013595. https:\/\/doi.org\/10.1016\/j.jmb.2007.06.006 (2007).","journal-title":"J. Mol. Biol."},{"key":"80622_CR16","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1186\/1471-2350-8-S1-S14","volume":"8","author":"DP Kiel","year":"2007","unstructured":"Kiel, D. P. et al. Genome-wide association with bone mass and geometry in the Fragmingham Heart Study. BMC Med. Genet. 8, S14. https:\/\/doi.org\/10.1186\/1471-2350-8-S1-S14 (2007).","journal-title":"BMC Med. Genet."},{"key":"80622_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00223-001-1035-9","volume":"70","author":"AM Qureshi","year":"2002","unstructured":"Qureshi, A. M., Herd, R. J., Blake, G. M., Fogelman, I. & Ralston, S. H. COLIA 1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy. Calcif. Tissue Int. 70, 158\u2013163. https:\/\/doi.org\/10.1007\/s00223-001-1035-9 (2002).","journal-title":"Calcif. Tissue Int."},{"key":"80622_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","volume":"42","author":"R Rizzoli","year":"2008","unstructured":"Rizzoli, R. et al. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42, 841\u2013847. https:\/\/doi.org\/10.1016\/j.bone.2008.01.003 (2008).","journal-title":"Bone"},{"key":"80622_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00784-009-0312-2","volume":"14","author":"MJ Simon","year":"2010","unstructured":"Simon, M. J., Niehoff, P., Kimmig, B., Wiltfang, J. & A\u00e7il, Y. Expression profile and synthesis of different collagen type I, II, III and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin. Oral. Investig. 14, 51\u201358. https:\/\/doi.org\/10.1007\/s00784-009-0312-2 (2010).","journal-title":"Clin. Oral. Investig."},{"key":"80622_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Ponten","year":"2008","unstructured":"Ponten, F., Jirstrom, K. & Uhlen, M. The Human Protein Atlas\u2014a tool for pathology. J. Pathol. 216, 387\u2013393. https:\/\/doi.org\/10.1002\/path.2440 (2008).","journal-title":"J. Pathol."},{"key":"80622_CR21","doi-asserted-by":"publisher","first-page":"e44636","DOI":"10.1371\/journal.pone.004636","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis. PLoS ONE 7, e44636. https:\/\/doi.org\/10.1371\/journal.pone.004636 (2012).","journal-title":"PLoS ONE"},{"key":"80622_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/odi.12632","volume":"23","author":"P Fung","year":"2017","unstructured":"Fung, P. et al. Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study. Oral Dis. 23, 477\u2013483. https:\/\/doi.org\/10.1111\/odi.12632 (2017).","journal-title":"Oral Dis."},{"key":"80622_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00796","author":"SM Jung","year":"2018","unstructured":"Jung, S. M., Han, S. & Kwon, H. Y. Dose-intensity of bisphosphonates and the risk of osteonecrosis of the jaw in osteoporosis patients. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.00796 (2018).","journal-title":"Front. Pharmacol."},{"key":"80622_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/ccd.ccd_696_17","volume":"9","author":"PS Sankar","year":"2018","unstructured":"Sankar, P. S. et al. Osteonecrosis of the jaw among patients receiving antiresorptive medication: a 4-year retrospective study at a Tertiary Cancer Center, Kerala India. Contemp. Clin. Dent. 9, 35\u201340. https:\/\/doi.org\/10.4103\/ccd.ccd_696_17 (2018).","journal-title":"Contemp. Clin. Dent."},{"key":"80622_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5624\/isd.2017.47.1.45","volume":"47","author":"HG Jeong","year":"2017","unstructured":"Jeong, H. G. et al. Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates. Imaging Sci. Dent. 47, 45\u201350. https:\/\/doi.org\/10.5624\/isd.2017.47.1.45 (2017).","journal-title":"Imaging Sci. Dent."},{"key":"80622_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/odi.12966","volume":"25","author":"SY Jung","year":"2018","unstructured":"Jung, S. Y., Suh, H. S., Park, J. W. & Kwon, J. W. Drug Holiday Patterns and Bisphosphonate-related Osteonecrosis of the Jaw. Oral Dis. 25, 471\u2013480. https:\/\/doi.org\/10.1111\/odi.12966 (2018).","journal-title":"Oral Dis."},{"key":"80622_CR27","volume-title":"Six Countries, Six Reform Models: The Health Reform Experience of Israel, the Netherlands, New Zealand, Singapore Switzerland and Taiwan. Hackensack","author":"TM Cheng","year":"2009","unstructured":"Cheng, T. M. Taiwan\u2019s National Health Insurance system: high value for the dollar. In Six Countries, Six Reform Models: The Health Reform Experience of Israel, the Netherlands, New Zealand, Singapore Switzerland and Taiwan. Hackensack (eds Okma, K. G. H. & Crivelli, L.) (World Scientific, Singapore, 2009)."},{"key":"80622_CR28","doi-asserted-by":"publisher","first-page":"e014807","DOI":"10.1136\/bmjopen-2016-014807","volume":"7","author":"CC Chang","year":"2017","unstructured":"Chang, C. C. et al. Primary Sjogren\u2019s syndrome and the risk of acute pancreatitis: a nationwide cohort study. BMJ Open 7, e014807. https:\/\/doi.org\/10.1136\/bmjopen-2016-014807 (2017).","journal-title":"BMJ Open"},{"key":"80622_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2173-5743(11)70024-7","volume":"7","author":"G Hernandez-Molina","year":"2011","unstructured":"Hernandez-Molina, G. & Michel-Peregrina, M. L. Sjogren\u2019s syndrome and pancreatic affection. Reumatol. Clin. 7, 130\u2013134. https:\/\/doi.org\/10.1016\/S2173-5743(11)70024-7 (2011).","journal-title":"Reumatol. Clin."},{"key":"80622_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00198-012-2042-6","volume":"24","author":"DH Solomon","year":"2013","unstructured":"Solomon, D. H. et al. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos. Int. 24, 237\u2013244. https:\/\/doi.org\/10.1007\/s00198-012-2042-6 (2013).","journal-title":"Osteoporos. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80622-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:12:21Z","timestamp":1670033541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80622-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80622"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80622-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1612"}}